Articles by Karen Pallarito

Brenda Gavin By Karen Pallarito The making of a venture capitalist. RELATED ARTICLES A Region Defined Did You Know? A Rich Life Science Cluster Greater Philadelphia's Big Pharmas A Robust Support Infrastructure Barbara Schilberg: Champion for the region Bridging the Gap Investment Momentum Building Update Those Resumes Creating Roots Ramping Up Tech Transfer DUSTIN FENSTERMACHER / WONDERFUL MACHINE Long before Brenda Gavin began i

1 Getting students to the region is not so much the issue as is keeping them here after graduation. To that end, the region's academic institutions are taking steps to counter any trend of brain drain. The partnership, Campus Philly, seeks to match students with local employment opportunities and maintains Careerphilly.com, where students can find information on jobs and internships in the region. "We work with the Life Science Career Alliance (a local organization that promotes workforce

Mark Tykocinski By Karen Pallarito Open doors lead a scientist to his calling. RELATED ARTICLES Successful Strategies Margaret Foti: Devoted to cancer research The Launch and the Exit Entrepreneurs Boldly Break New Ground Shire Pharmaceuticals: A Study in Exponential Growth Many Happy Returns: Cephalon celebrates its 20th year Creative Collaboration DUSTIN FENSTERMACHER / WONDERFUL MACHINE In the summer of 1971, Yale undergraduate Mar

Art Caplan By Karen Pallarito A conversation with Penn's renowned ethicist. RELATED ARTICLES Innovative Technology Daniel Skovronsky: Scientist and leader Turning Tobacco into Therapies Biofuel: The Potential Magic Bullet Britton Chance: Still searching for answers Technology Roundup DUSTIN FENSTERMACHER / WONDERFUL MACHINE As a Columbia University philosophy student in the 1970s, Arthur Caplan listened to ongoing discussions about the ethics of

Aprotinin's safety profile remains in question in absence of full data disclosure

Survey finds new student enrollment is up in the life sciences, but questions about broader recovery loom

The Life Sciences Salary Survey Compensation soars as demand for highly-skilled professionals heats up. By Karen PallaritoRelated Articles: Salary by Highest Degree Earned Salary by Area of Specialization Salary by Gender Salary by Ethnicity Salary Map: salaries and costs of living in 19 US metropolitan areas Salary Charts Salary by Job Activity, type of research, age, and job title 2006 Salary Survey Methodology Salary Survey ArchiveThe que

The Life Sciences Salary Survey: Methodology By Karen PallaritoRelated Articles: Salary by Highest Degree Earned Salary by Area of Specialization Salary by Gender Salary by Ethnicity Salary Map: salaries and costs of living in 19 US metropolitan areas Salary Charts Salary by Job Activity, type of research, age, and job title 2006 Salary Survey Salary Survey ArchiveThe survey, ?Compensation of Life Scientists in the USA,? was conducted by Abbot

By Karen Pallarito The Feminine Touch Women are joining forces to invest in life science ventures, and getting results. "We feel there's a huge opportunity to be able to support the initiatives that these women are going to want to take in terms of entrepreneurship and growing businesses." — Donna

By Karen Pallarito Sonya Summerour Clemmons Director of Business Development, MediVas, LLCBusiness Founder and Owner, SSC Enterprises © BLACK ENTERPRISE MAGAZINE Growing up in Gainesville, Ga., Sonya Summerour Clemmons could have easily made excuses not t

Survey reveals undercurrent of discontent, fueling questions about the future of NIH

Going from academia to business - and back again - is no easy feat. The exceptions not only prove the rule, but also that it can be done.

Multiple PIs

The move, caused by frustration with US stem cell policy, may bode poorly for the future of American efforts in this field, experts say

FEATUREBest Places to Work 2006: Industry   Courtesy of Transform PharmaceuticalsWhat makes a company a great place to work? In our fourth annual survey, industry scientists share their insights.BY KAREN PALLARITOBrian Hopkins, a PhD research scientist and project leader at Infinity Pharmaceuticals, joined the Cambridge, Mass., company in May 2002 partly because he liked its DOS (diversity-oriented synthesis